Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Sales and marketing

General and administrative

Restructuring

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Doximity

Doximity, Inc. develops an online healthcare resource and interactive platform. The Company cloud-based platform enables its members to collaborate with their colleagues, securely coordinate patient care, and conducts virtual patient visits. Doximity serves customers in the United States.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Doximity surpasses Q4 revenue expectations and eyes continued growth

Doximity's Q4 2023 performance exceeded expectations, showcasing strong financial metrics and strategic investments. The company's outlook for Q1 2024 indicates continued growth, with a focus on topline expansion and product innovation. While facing challenges in pricing strategies and competitive landscape, Doximity is well-positioned to capitalize on opportunities in the healthcare technology sector.

Doximity reports strong Q1 results but lowers 2024 guidance

Doximity delivered strong financial performance in Q1, but challenges in upsell close rates led to a downward revision in annual guidance. The company's focus on innovation, expansion, and shareholder value, along with a cautious outlook for the remainder of the year, presents a mixed picture of opportunities and challenges for investors.

Doximity reports strong Q3 earnings, eyes growth amid product challenges

Doximity's Q3 performance demonstrated resilience and growth potential despite challenges in meeting annual guidance due to product delays.
The company's focus on innovation, strong client relationships, and strategic investments position it well for future growth and market leadership.
With a commitment to R&D, expanding product offerings, and maintaining pricing discipline, Doximity aims to capitalize on opportunities and navigate challenges for sustained success.

Doximity surpasses Q4 revenue targets, poised for growth and innovation

Doximity's Q4 performance exceeded expectations, with robust revenue growth, strong margins, and strategic investments in new products and talent.
While facing challenges like flat growth in certain segments and pricing adjustments, the company is well-positioned to capitalize on opportunities in network expansion and technology innovation.
With a focus on enhancing user experience, driving engagement, and optimizing revenue streams, Doximity is poised for continued success and value creation for shareholders.
The company's financial health, innovative product offerings, and market positioning indicate a promising outlook for sustained growth and competitive advantage in the healthcare technology sector.

Doximity surpasses Q1 revenue expectations, faces upsell challenges

Doximity's Q1 performance was strong, but challenges in upsells prompted a staff reduction and revised guidance. The company is optimistic about long-term growth, leveraging new products and a self-serve ad platform for future success.

Doximity beats Q2 expectations, eyes growth amidst market uncertainties

Doximity's strong Q2 performance exceeded revenue and EBITDA guidance, driven by record physician engagement and new product success.
While facing market uncertainties and competition challenges, the company sees opportunities in pricing strategies and continued growth.
Investments in high-touch services, Telehealth, and video products are paying off, with a focus on enhancing client offerings.
Integration with IQVIA for real-time ROI analysis positions Doximity for future growth and client value creation.

Doximity beats Q3 revenue, eyes growth through AI products

Doximity's Q3 performance exceeded expectations with strong revenue and margin growth. The company faces challenges with elongated sales cycles but has opportunities for growth through AI products and new modules. Overall, Doximity's competitive position remains strong in the market.

Doximity exceeds Q4 revenue, eyes mid-teens growth post-COVID

Doximity's Q4 earnings call highlighted strong financial performance, customer satisfaction initiatives, and growth opportunities in digital marketing and new business segments. While facing challenges in growth slowdowns and market uncertainties, the company is leveraging strengths in optimized margins, visibility into revenue guidance, and customer commitment to drive future success.

Doximity excels in Q1 2025, driving growth through client value

Doximity's Q1 2025 performance reflects strong revenue growth, operational efficiency, and client value proposition.
The company's focus on innovation, customer engagement, and strategic insights positions it well for sustained growth.
Despite challenges, Doximity's proactive approach to industry dynamics and growth opportunities bodes well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Dr. Nate Gross, co-founder and chief strategy officer, will present at the William Blair 43rd Annual Growth Stock Conference on Thursday, June 8, 2023 at 10:00 a.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across.

Doximity to Present at the William Blair 43rd Annual Growth Stock Conference

Doximity Inc. NASDAQ: DOCS is a digital professional social network platform for medical practitioners. It's a medical community networking platform like a Microsoft Co. NASDAQ: MSFT owned LinkedIn that enables doctors to communicate, interact and share information.

Doximity is an Overlooked Medical Ecosystem AI Play

Uber

Studying the activity of billionaire investors is one way to jump-start your stock-picking process. Steven Cohen's Point72 fund made a big bet on Doximity, a social media platform for physicians, in the first quarter.

2 Growth Stocks Billionaires Keep Buying Hand Over Fist

Medical platform Doximity's disappointing guidance overshadowed a strong quarterly report. Nonetheless, two analysts raised revenue outlooks.

Doximity Stock Is Sinking. Some Bulls Aren't Budging.

Wix.com

Stock markets looked poised to recover some of their recent losses on Wednesday morning. Wix.com shares moved higher as the website facilitator lauded its AI efforts.

SaaS Stocks Aren't Out of the Woods Just Yet

Doximity, Inc. (NYSE:DOCS ) Q4 2023 Earnings Conference Call May 16, 2023 5:00 PM ET Company Participants Perry Gold - Head, IR Jeffrey Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Founder and CSO Conference Call Participants Brian Peterson - Raymond James Scott Berg - Needham Richard Close - Canaccord Genuity Sandy Draper - Guggenheim Securities Ryan Daniels - William Blair Stan Berenshteyn - Wells Fargo Securities Stephanie Davis - SVB Securities Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI David Larsen - BTIG Operator Hello, and welcome to Doximity's Fiscal Q4 2023 Earnings Call. I will now pass the call over to Doximity's Vice President of Investor Relations, Perry Gold, to kick off the call.

Doximity, Inc. (DOCS) Q4 2023 Earnings Call Transcript

Doximity (DOCS) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.21 per share a year ago.

Doximity (DOCS) Q4 Earnings and Revenues Top Estimates

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with MEDITECH, one of the most widely used electronic health record (EHR) systems in the United States. The integration enables medical professionals to launch a Doximity Dialer voice or video telehealth visit directly from MEDITECH's physician-facing native app, Expanse Now. With this easy-to-use native app integration, medical professionals c.

Doximity Announces New Integration with MEDITECH

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2023 fourth quarter and fiscal year ended March 31, 2023. The company also announced the appointment of two new senior leadership members, Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products. “With the public health emergency officially over, we're proud to emerge with a record number of provide.

Doximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires

IDEXX Laboratories

Teladoc

Teladoc looks to transition from a high-flying growth story to a profitable enterprise. Doximity's early profitability and cash generation point to incredible potential ahead.

3 Best Stocks to Buy in May and Hold Forever

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ended March 31, 2023 after market close on May 16, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before.

Doximity to Release Fiscal 2023 Fourth Quarter Results on May 16, 2023

Autodesk

Five9

Since ChatGPT was released last November, artificial intelligence stocks have become all the rage. As a result, every media company engaged with consumers had to have its own Chatbot.

The Top 3 Artificial Intelligence Stocks to Watch

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its annual Physician Compensation Report, revealing a slight decline of 2.4% in average pay for doctors in 2022. The report includes self-reported compensation data from over 190,000 U.S. doctors over six years and over 31,000 full-time physicians in the last year alone. The decline in physician compensation comes at a time when U.S.

Doximity Releases New Study on Physician Compensation and Impact of Overwork and Economic Pressures

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will host an Investor Day on Tuesday, June 6, 2023. The event will be held at the New York Stock Exchange in New York City from 10:30 a.m. to 1:30 p.m. Eastern Time. To view a live webcast of the event, please visit the Company's Investor Relations page at https://investors.doximity.com/.

Doximity to Host Inaugural Investor Day June 6, 2023

Shockwave Medical

Transmedics Group Inc

Individual stocks don't deliver 10x returns very often, but it does happen. Doximity operates a social media platform exclusive to U.S. medical professionals, and pharmaceutical companies are clamoring for its available ad inventory.

Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years

SoFi Technologies

Soaring interest rates have shares of the best and worst growth stocks under a lot of pressure. SoFi Technologies is a digital bank that trades below its book value even though it's growing by leaps and bounds.

2 Top Growth Stocks to Buy Before the Next Bull Rally

Doximity is testing an AI tool that could save doctors a lot of time. The healthcare company already is a favorite of doctors, with more than 80% of them using the platform.

Could AI Supercharge This Growth Stock?

Some of the growth stocks that were beaten mercilessly in 2022 are still trading at sensible valuations. Doximity is a social media platform viewed regularly by roughly 80% of America's physicians.

2 Beaten-Down Growth Stocks to Buy on the Dip

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023, at 9:15 a.m. Eastern Time/6:15 a.m Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S.

Doximity to Participate in the Raymond James 44th Annual Institutional Investors Conference

Doximity's earnings have climbed as it attracts more users and advertisers. But the share performance hasn't reflected the company's successes.

Doximity Stock: Bear vs. Bull

Investors haven't had any reasons to be bullish about the stock in a long time. Do they now?

Doximity Stock: Bull vs. Bear

Does this make Doximity a no-brainer buy?

Doximity Is Getting In on the ChatGPT Hype

CRISPR Therapeutics

Vertex Pharmaceuticals

Doing this can strengthen your retirement plan.

Here's How Much You Can Make From Investing Your Tax Return Every Year

Trade Desk

Despite disappointing stock market performances, billionaires keep buying these growth stocks like there's no tomorrow.

2 Exceptional Growth Stocks Down 49.6% to 67.1% That Billionaires Keep Buying

OpenAI's generative AI technology could open new opportunities for Doximity.

News for Doximity Stock (DOCS)